One Juliet and four RomeosVeA and its methyltransferases

Four. That's the number of methyltransferase partners a single fungal protein, VeA, appears to juggle. Four molecular partners, all converging on the same hub. The question that drives this entire story is a simple one: why does one protein need four? The answer, it turns out, tells us something fundamental about how fungi decide what chemicals to make, when to reproduce, and how to become dangerous. Fungi are extraordinary chemists. Penicillin came from a fungus. So did the cholesterol-lowering statins, and so did mycotoxins like sterigmatocystin, a potent carcinogen that Aspergillus molds quietly synthesize in stored grain. The genes for making these compounds are physically clustered together on fungal chromosomes, known as biosynthetic gene clusters. Genome sequencing has revealed that fungi carry far more of these clusters than they ever express under ordinary conditions. Conservative estimates put the fungal kingdom at around five million species, of which only about 100,000 have been described. The bulk of fungal chemistry is still sitting there, silent, waiting. The central puzzle is: what decides which clusters get switched on? The first major answer came with the discovery of LaeA, a putative methyltransferase identified by Bok and Keller in 2004. A methyltransferase is an enzyme that attaches a methyl group, a tiny carbon tag, typically to DNA, histones, or proteins. That tag changes what genes get read. LaeA, it turned out, controls an enormous regulatory program. In several Aspergillus species, loss of LaeA affects roughly 50 percent of secondary metabolite gene clusters. In Aspergillus fumigatus, Perrin and colleagues showed that LaeA influences expression of 9.5 percent of the entire genome, with 13 of 22 secondary metabolite clusters strongly downregulated in its absence. Lose LaeA and you also get reduced pigmentation, reduced sporulation, and, in pathogenic species, reduced virulence. The obvious hypothesis was that LaeA rewrites chromatin. Reyes-Dominguez and colleagues showed that laeA mutants accumulate more of the repressive histone mark H3K9 trimethylation across the sterigmatocystin cluster, along with increased occupancy of the heterochromatin protein HepA and decreased activating marks. That's consistent with LaeA erasing repressive chromatin and opening clusters for transcription. But when Patananan and colleagues went looking for what LaeA actually methylates in vivo and in vitro, they found nothing. They did detect an unusual automethylation reaction producing S-methylmethionine, but mutating that site left LaeA fully functional. The enzymatic substrate of LaeA remains, plainly, unknown. It looks like a methyltransferase, behaves as if one is required for its function, and yet a decade of work has not produced the target. That's the central enigma. The story expanded when Bayram and colleagues discovered in 2008 that LaeA is not a lone actor; it participates in a heterotrimeric complex with two other proteins, VelB and VeA. VeA is the founding member of the velvet protein family, a group conserved across filamentous fungi that includes VeA, VelB, VosA, and VelC. VeA's original job, identified by Kato and colleagues, is as a light-response factor. Grown in the dark, Aspergillus nidulans undergoes sexual reproduction. In the light, it switches to asexual spore production. VeA is the pivot of that decision. In the dark, VeA is imported into the nucleus, chaperoned there by the importin KapA, where it forms the VelB–VeA–LaeA heterotrimer that coordinates sexual development with secondary metabolite production. In the light, VeA expression drops and its nuclear entry is reduced, tilting the fungus toward asexual development. VeA's structure offers a surprising evolutionary parallel. Ahmed and colleagues analyzed the crystal structure of a VosA–VelB heterodimer and found that the velvet domain folds into a shape resembling the Rel homology domain of NF-kappa-B transcription factors in mammals, proteins famous for integrating immune and stress signals in animals. The velvet family appears to use a similar fold for DNA binding, with VosA recognizing an eleven-nucleotide consensus sequence in promoters of asexual regulators and trehalose biosynthetic genes. The evolutionary resonance across kingdoms suggests this fold is a reliable solution to the problem of signal integration. VeA's role as a hub goes further. Purschwitz and colleagues showed it physically contacts the histidine-kinase domain of FphA, the red-light phytochrome, and interacts with the blue-light receptor pair LreA and LreB. Bayram and colleagues found that the MAP kinase MpkB phosphorylates VeA in vitro and interacts with it in the nucleus, with that phosphorylation promoting VeA–VelB heterodimer formation, though it doesn't affect the VeA–LaeA interaction. So VeA is integrating MAPK signaling, light sensing, importin-mediated nuclear trafficking, and methyltransferase partnerships simultaneously. Then the cast expanded again. Palmer and colleagues identified LlmF, LaeA-like methyltransferase F, as a third methyltransferase partner for VeA. Unlike LaeA, which is constitutively nuclear, LlmF shuttles between the nucleus and cytoplasm and acts as a negative regulator of sexual development. The key finding: loss of LlmF causes VeA to accumulate in the nucleus, with a corresponding increase in sterigmatocystin production and sexual reproduction. Overexpress LlmF and VeA gets pushed back to the cytoplasm, sexual development drops, and sterigmatocystin drops. LlmF appears to be controlling the nuclear-cytoplasmic balance of VeA itself. The SAM-binding motif of LlmF is required for its function, but again, no methylation substrate has been identified. The fourth and fifth partners come as a package. Sarikaya-Bayram and colleagues discovered VipC and VapB, a methyltransferase heterodimer, along with a membrane-anchored protein called VapA. Here's the logic of this system: VapA is a FYVE zinc-finger protein localized to the plasma membrane, and its job is to tether VipC–VapB at the membrane, holding them there until a signal triggers their release. When released, VipC–VapB travels to the nucleus and interacts with VeA. The effect on development mirrors LlmF: VipC–VapB negatively regulates sexual development and promotes asexual development. When VapA is absent, meaning nothing is tethering VipC–VapB at the membrane, VeA nuclear accumulation increases and sexual development rises. Overexpression of VapB shifts secondary metabolite output away from sterigmatocystin and toward orsellinic acid, and nearly halves global levels of H3K9 trimethylation while dramatically redistributing the heterochromatin protein HepA. Whether VapB directly demethylates histones or acts indirectly through VeA is unresolved. This is the same open question that shadows LaeA. What emerges from Sarikaya-Bayram and colleagues is a picture of VeA sitting at the intersection of membrane signaling, light responses, MAPK cascades, nuclear import machinery, and at least four methyltransferase partners. The review poses the question directly: is this a supercomplex where VeA coordinates all partners simultaneously, or is VeA a dynamic switchboard, cycling through different partnerships as conditions change? The evidence points more toward a switchboard. LlmF and VipC–VapB oppose VeA's nuclear accumulation, while LaeA works with nuclear VeA. The interactions appear mutually modulated, condition-dependent, and, in some cases, opposing. A single stable supercomplex containing all four methyltransferases would be hard to reconcile with their opposing functional effects. The conservation of this system across the fungal kingdom matters. Orthologous methyltransferases and Vip and Vap components appear in diverse fungal species well beyond Aspergillus, and laeA mutants show reduced virulence in Aspergillus fumigatus, Aspergillus flavus, Cochliobolus heterostrophus, and several Fusarium species. Understanding this regulatory network isn't just basic science; it points toward antifungal drug targets, toward controlling mycotoxin contamination in crops, and toward unlocking the silent biosynthetic gene clusters that genomics keeps revealing in newly sequenced fungal genomes. What the field needs now is structural biology. There is a partial crystal structure of VosA–VelB, but the full VelB–VeA–LaeA heterotrimer has not been resolved at high resolution, and the architecture of any larger assembly involving LlmF or VipC–VapB is entirely unknown. Without that structural picture, we can't know how these partners share VeA's binding surfaces, whether simultaneously or sequentially, or how methyltransferase activity is coupled to complex assembly. The most basic question, what does LaeA methylate, remains open after more than a decade of effort. Five million fungal species, most of their chemistry undiscovered. The velvet network is the lock. The key is still being cut. This lecture was created by ennepō. Go to https://ennepo.ai to Discover, Create and Follow the latest research in your field. Read when you can. Listen when you want to.